Hidefumi Kishikawa
Papers
1
Total Citations
1
H-Index
1
About
Hidefumi Kishikawa is a urologic oncologist whose research focuses on improving surgical outcomes for bladder cancer patients. His work centers on identifying preoperative biomarkers and clinical factors that predict postoperative recovery trajectories, with particular emphasis on inflammatory markers such as C-reactive protein (CRP). In his landmark 2025 study, Kishikawa demonstrated that elevated preoperative CRP levels serve as a significant predictive factor for prolonged hospital stays following radical cystectomy—the gold-standard curative treatment for localized bladder cancer. By retrospectively analyzing patient characteristics, laboratory data, surgical variables, and postoperative complications, he provided clinicians with a practical tool for risk stratification and perioperative planning. This research contributes to the growing field of precision medicine in urologic oncology, where simple, cost-effective biomarkers can guide resource allocation and patient counseling. While his work is still accumulating citations, Kishikawa’s investigation into modifiable and non-modifiable risk factors for extended hospitalization addresses a critical gap in optimizing recovery pathways for bladder cancer patients undergoing major pelvic surgery.
Research Focus
Key Achievements
Top Papers
- 1